Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future
Hims & Hers' stock price has swung wildly this year. The telehealth company's public feud with drugmaker Novo Nordisk knocked ...
Read moreDetailsHims & Hers' stock price has swung wildly this year. The telehealth company's public feud with drugmaker Novo Nordisk knocked ...
Read moreDetails
